Laboratoires Théa has penned a deal potentially worth up to $280 million to get its hands on Iolyx Therapeutics’ phase…

Muvon Therapeutics has linked its cell therapy to a 60% drop in stress incontinence episode frequency in a small phase 2…

In the relentless pursuit of more effective cancer treatments, a burgeoning field of research has been focusing on an intricate…

In the realm of pediatric nephrology, accurately assessing kidney function is paramount for diagnosing and managing renal diseases. A crucial…

In the realm of diabetes management, the continuous evolution of treatment strategies has brought renewed hope to millions of patients…

In the ongoing battle against antibiotic resistance, researchers are increasingly turning to the natural world in search of potent antibacterial…

In the realm of valvular heart disease, the landscape of patient treatment and care is on the verge of a…

In a groundbreaking advancement that could redefine therapeutic approaches to chronic immunological skin disorders, a team of researchers led by…

In a groundbreaking advance amidst the challenges of neonatal intensive care, recent research reveals that reduced heart rate variability (HRV)…

In a groundbreaking study set to reshape our understanding of plant-microbe interactions, researchers led by Jannesar, Bassami, and Dalir have…